Company intelligence / Profile preview

Matterworks

Somerville, Massachusetts, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Matterworks provides an AI-driven metabolomics and omics-analysis platform (including the Pyxis product and a Large Spectral Model) used by biopharma and biological researchers to generate rapid, quantitative metabolite profiles and extract biological insights from raw spectral and omic data; it is a tools/software company and does not run its own therapeutic clinical trials.[2][3][5]

Industry: Drug Discovery Services

Partnerships

Collaborations and beta trials with top pharmaceutical firms for Pyxis (names not publicly specified).[2]

Beyond the preview

Go deeper on Matterworks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matterworks.

Explore the full profile